Forum

Notifications
Clear all

FDA on Recalled Items

51 Posts
51 Users
0 Reactions
6,007 Views
(@kcbutlermsm-edu)
Posts: 27
Eminent Member
 
The FDA instructed all makers of surgery mesh goods used for pelvic organ prolapse (POP) repair to cease advertising and marketing their goods throughout the United States instantaneously in April 2019. Since the FDA reclassified these devices in class III (high risk) in 2016, the agency determined that the manufacturers, Boston Scientific and Coloplast, had not shown a reasonable assurance of safety and effectiveness, which is the premarket review standard that now applies to them. Manufacturers were required to submit and receive approval for premarket approval (PMA) applications, the company's most rigorous device review pathway, as part of the 2016 reclassification to keep advertising their products in the United States. Boston Scientific and Coloplast were given ten days to submit their plans for withdrawing these products from the market. The manufacturers of these transvaginal mesh slings should have reacted before 2019 to resolve the issues with complications many patients endured. When patients began presenting side effects and addressing concerns to their doctors, the physicians should have escalated that information back to the manufacturer’s sales representatives. Thus, the feedback would have quickly escalated back to the manufacturers to notify the FDA of the issue to enforce an immediate recall of the products. The FDA is responsible for the recall since they are the ones who initially approved the product to be placed on the market and used to treat POP. However, millions of people had to have these surgical meshes removed since they were causing excrutiating pain and discomfort. 

 
 
 
Posted : 17/03/2023 5:50 pm
(@magan-rhodes)
Posts: 24
Eminent Member
 

Transvaginal mesh has been recalled numerous times. This medical device is used to treat pelvic organ prolapse. I would not say that the FDA is completely at fault. The FDA did approve the product but we are not certain of the other factors that went into the decision.

Often times, some of the trials the devices undergo are not as extensive as the public would like, but items are fast tracked when there is a high need. Another factor that is considered is whether the results outweigh the side effects. Additionally, the clinical trials are tested on a diverse population, but there is no way to predict all outcomes the device will face with every individual it comes into contact. 

For example, the J&J COVID-19 vaccine was approved then recalled after adverse side effects were revealed. The vaccine was pushed through FDA approval quickly to meet the public need. Every person, who received the vaccine, did not experience bad side effects, but enough people did for them to recall it. Was the FDA at fault? Did the public outcry play a part in the rapid approval process?

I cannot place the blame solely on the FDA.

 
Posted : 18/03/2023 1:59 pm
(@danieshat1)
Posts: 22
Eminent Member
 

I do not think that everything that causes a recall I because of the FDA. Things such as sterilization comes from responsibility of the company. It is up to the company to make sure the things that they manufacture and distribute is of quality, safety, and efficacy. Checking for sterilization debris is essential, but the FDA does not work at the facility all day every day, so they can't guarantee that the company's workers are following protocol and double checking. 

 
Posted : 18/03/2023 6:54 pm
(@cpierrelouis)
Posts: 30
Eminent Member
 

The U.S. FDA has the job of preserving the public health of all U.S. consumers through the regulation of a potential health risks; which includes human and veterinary drugs, biological products, medical devices, food, cosmetics, and products that put out radiation. While the FDA's mission is to look out for consumers, many previously-approved items have resulted in recalls, long-term injuries, and lawsuits, calling into question the efficacy of their approval process. 

 
Posted : 19/03/2023 2:47 pm
(@jh597)
Posts: 78
Trusted Member
 

Over the course of the last year, the FDA recalled Smiths Medical's Computerized Ambulatory Delivery Device pump, which is a combination product which delivers a drug at a programmed time and dose. This device was recalled due to issues with dosing accuracy in which blockage would occur in the tube, resulting in under-dosing or over-dosing. This recall is an example of a quality recall in which the functionality of the device has shown to potentially yield inaccurate dosage. The FDA labeled this recall as Class I, which is the highest degree of a health risk. Different types of recalls may include issues with quality, and sterility as well as changes in regulations over time. In this case, the FDA would be considered responsible since they approved the use of the device. All potential failure modes should be assessed and the potential risk should be evaluated to determine whether the device is ready to be approved or if further modifications need to occur. 

 
Posted : 26/09/2023 9:30 pm
(@sah67)
Posts: 78
Trusted Member
 

Hello,

While the FDA conducts extensive testing and requires substantial documentation for approval, recalls do occur. Several medical products have experienced recalls over the years, including both drugs and devices. These recalls happen for various reasons, often related to safety concerns or unexpected adverse effects. For instance, some drugs may be recalled due to newly discovered side effects that were not apparent during initial testing, or because of manufacturing issues that may have compromised product quality. Similarly, medical devices might be recalled if they malfunction, pose a risk to patients, or fail to perform as intended. In many cases, the FDA acts responsibly by issuing recalls when necessary to protect public health. Their rigorous approval process is designed to minimize the risk of recalls, but it is impossible to predict all potential issues in advance. Recalls are often the result of unforeseen complications that may not have been evident during the initial stages of testing and approval.

 
Posted : 01/10/2023 10:08 am
Page 4 / 4
Share: